• Mashup Score: 1

    The EORTC PAMM Meeting will be held in Marseille, France on 7-10 February 2024 and is open to individual or site staff members, as well as external

    Tweet Tweets with this article
    • Don't miss your chance to exchange scientific insights and data with the primary European #oncology and #pharmacology community at the EORTC PAMM meeting in Marseille on 7-10 February 2024. More: https://t.co/Dy5CovhBWL #CancerResearch #ClinicalTrials https://t.co/5srTFJuNzN

  • Mashup Score: 0
    Fellows 2023 - 11 month(s) ago

    It’s the annual CRF Interventional Cardiology Fellows Course — a hands-on education program covering key concepts in interventional cardiovascular medicine. Fellows, experienced physicians, and other members of the heart team will learn and refresh skills in all facets of coronary, structural, and endovascular interventions. View the course overview page to view who should attend, topics covered,…

    Tweet Tweets with this article
    • Part 2 of Fundamental Concepts in PCI begins at 2:15 PM EDT. Featuring the evolution of PCI #pharmacology and a keynote lecture from @JWMoses #CardioEd #Fellows2023 https://t.co/jDgH7lkXHA @DougDrachmanMD @cardioPCImom @BinitaShahMD @nadia_sutton @rwyeh https://t.co/VRDUxtfBvp

  • Mashup Score: 3

    ACC Anywhere provides easy access to all of ACC’s video content in one location. You can easily search and browse presentations and watch Collections anytime, anywhere with on demand access. Collection PH 202: Navigating Complex Clinical Scenarios in Pulmonary Arterial Hypertension – A “March Matchup” Session PH 202: Navigating Complex Clinical Scenarios in Pulmonary Arterial Hypertension – A…

    Tweet Tweets with this article
    • Review common pharmacokinetics & pharmacodynamics interactions of CV 💊 in oncology patients, & more w/ ACC Anywhere on demand access to #Pharmacology session: Pharmacists Are Your BFFs in #CardioOnc—CV 💊 Interactions to Be Aware of in Oncology Patients. https://t.co/ZduofUwLSM https://t.co/b4cX9mSab0

  • Mashup Score: 0

    From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.

    Tweet Tweets with this article
    • Exciting new drug candidates are set for FDA review in Q2 2023! Don't miss the PDUFA dates for SER-109, B-VEC, sotagliflozin, mavacamten, and aflibercept 8 mg. #pharmacology #FDA https://t.co/Sezy8TSEwp

  • Mashup Score: 0

    From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.

    Tweet Tweets with this article
    • Exciting new drug candidates are set for FDA review in Q2 2023! Don't miss the PDUFA dates for SER-109, B-VEC, sotagliflozin, mavacamten, and aflibercept 8 mg. #pharmacology #FDA https://t.co/cRFXBZjYoK

  • Mashup Score: 0

    In spite of the development of numerous vaccines for the prevention of COVID-19 and the approval of several drugs for its treatment, there is still a great need for effective and inexpensive therapies against this disease. Previously, we showed that green tea and tea catechins interfere with coronavirus replication as well as coronavirus 3CL protease activity, and also showed lower COVID-19…

    Tweet Tweets with this article
    • #GreenTea Consumption and the #COVID19 #Omicron #Pandemic Era: #Pharmacology and #Epidemiology https://t.co/OJFoyf25vE https://t.co/y9qoeNZpGA

  • Mashup Score: 2

    FDA Special Session: Background Medical Therapy for HF Clinical TrialsMission Impossible: Challenging Cardiogeic Shock CasesHypertrophic Cardiomyopathy: It’s a New Dawn And I’m Feeling GoodSunday Plenary Session: Late Breaking Clinical TrialsNew Concepts and Controversies in Pulmonary Hypertension and Right Ventricular FailureLet’s Talk About Sex (Differences in Heart failure)Multidisciplinary…

    Tweet Tweets with this article
    • Pharmacists, here's your chance to earn up to 20.75 valuable CPE credits from 19 key sessions that were held at ASM '22. 📢SESSION HIGHLIGHT: Learn more about specific #pharmacology updates in #HFrEF from @BiykemB @MKIttlesonMD @orlyvardeny & @NutritionHF! https://t.co/ysR8Zv283u https://t.co/UaRUQyKgmn